This session includes a clinically focused debate on the evolving role of interventional strategies — including catheter-directed thrombolysis and surgical embolectomy — versus optimized medical therapy in the management of VTE. The session critically evaluates current evidence, patient selection criteria, risk-benefit considerations, and the growing armamentarium of endovascular options for pulmonary embolism and DVT.